Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Acamprosate + Lubiprostone
|
DC9ICGV
|
Acamprosate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Acitretin + Lubiprostone
|
DCTF8ZB
|
Acitretin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Arfolitixorin + Lubiprostone
|
DCPVK5R
|
Arfolitixorin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Bepridil + Lubiprostone
|
DC0SVKA
|
Bepridil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Bosentan + Lubiprostone
|
DC4Q46F
|
Bosentan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Brincidofovir + Lubiprostone
|
DCFS8ZO
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Cerivastatin + Lubiprostone
|
DC4GNP4
|
Cerivastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Chlorzoxazone + Lubiprostone
|
DCB4G07
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Cisatracurium + Lubiprostone
|
DCA6Y9W
|
Cisatracurium
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Clindamycin + Lubiprostone
|
DCPJR1G
|
Clindamycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Dantrolene + Lubiprostone
|
DCY4HGS
|
Dantrolene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Ezetimibe + Lubiprostone
|
DCKJ846
|
Ezetimibe
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Baclofen
|
DC8WGR4
|
Baclofen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Diethylcarbamazine
|
DC0EHX4
|
Diethylcarbamazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Imipramine
|
DCF1C4T
|
Imipramine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Epinephrine
|
DCDFIL0
|
Epinephrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Vinblastine
|
DCC06SS
|
Vinblastine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Sivelestat
|
DCQTSIT
|
Sivelestat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Anamorelin
|
DCFSX7N
|
Anamorelin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Triapine
|
DC75X39
|
Triapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + IT-141
|
DCBWSKF
|
IT-141
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Methylergonovine
|
DCPSP9E
|
Methylergonovine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Metyrosine
|
DC8IUML
|
Metyrosine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Terameprocol
|
DCW2S39
|
Terameprocol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Itraconazole
|
DC3PC3O
|
Itraconazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Carglumic acid
|
DCD782Q
|
Carglumic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Pazopanib
|
DCGLYKA
|
Pazopanib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Fluspirilene
|
DC5XWQ3
|
Fluspirilene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Niclosamide
|
DCCN7UL
|
Niclosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + GINKGOLIDE A
|
DCY19YP
|
GINKGOLIDE A
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Diazoxide
|
DCG2X7P
|
Diazoxide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Idarubicin
|
DCBUW8R
|
Idarubicin
|
Glioblastoma? (Cell Line: T98G)
|
[2] |
Lubiprostone + Imatinib
|
DCTVZTC
|
Imatinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Pramipexole
|
DCVYC8H
|
Pramipexole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Methylene blue
|
DC6XEGW
|
Methylene blue
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Maprotiline
|
DCT60Q0
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Brincidofovir
|
DCYHHE2
|
Brincidofovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Mycophenolic acid
|
DCVMY0I
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Doxorubicin
|
DCPF6N8
|
Doxorubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Sumatriptan
|
DCM5VQ2
|
Sumatriptan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Auranofin
|
DCXUQFX
|
Auranofin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + PMID28870136-Compound-43
|
DCQR010
|
PMID28870136-Compound-43
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Cerivastatin
|
DC8W1WH
|
Cerivastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Lubiprostone + Cytarabine
|
DCKTUKD
|
Cytarabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Maprotiline + Lubiprostone
|
DCB73OG
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Moricizine + Lubiprostone
|
DCNW7JU
|
Moricizine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Nizatidine + Lubiprostone
|
DC1JDIO
|
Nizatidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Quinine + Lubiprostone
|
DCKD9S1
|
Quinine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Ramelteon + Lubiprostone
|
DC1UMF4
|
Ramelteon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Theophylline + Lubiprostone
|
DC85KNG
|
Theophylline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Tiagabine + Lubiprostone
|
DCH81LP
|
Tiagabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Topotecan + Lubiprostone
|
DCH5AQJ
|
Topotecan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
Triflupromazine + Lubiprostone
|
DC2MTRJ
|
Triflupromazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
Tropisetron + Lubiprostone
|
DCC853L
|
Tropisetron
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
WAY-100635 + Lubiprostone
|
DCDQ0RM
|
WAY-100635
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
------------------------------------------------------------------------------------ |
|
|
|
|